Whenever a drug has been prescribed with the indication "Do Not Substitute" for a patient who has a contract whereunder he is reimbursed for the costs of health care, then the party that has contracted to reimburse the patient shall make the reimbursement on the basis of the brand name price and not on the basis of the generic drug price.
KRS 217.826
Basis for reimbursement when substitution forbidden
History: Created 1972 Ky
Official source: Kentucky General Assembly. Reproduced from public-domain Kentucky statutes; confirm against the official source for the current text. Not legal advice.